InvestorsHub Logo
Post# of 252255
Next 10
Followers 5
Posts 993
Boards Moderated 0
Alias Born 06/15/2010

Re: None

Monday, 06/04/2012 12:42:13 AM

Monday, June 04, 2012 12:42:13 AM

Post# of 252255
According to Feuerstein on Ponatinib:

54% major cytogenic response up from 47% in December
70% major cytogenic response up from 65% in the T315 subgroup
Pancreatitis unchanged at 6%

Full report in the AM. Good luck to the Ariad holders (and the non-Ariad holders as well) on the BV board.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.